517 related articles for article (PubMed ID: 30944831)
1. The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression.
Lee SS; Cheah YK
J Immunol Res; 2019; 2019():3046379. PubMed ID: 30944831
[TBL] [Abstract][Full Text] [Related]
2. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
3. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
4. miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.
Florczuk M; Szpechcinski A; Chorostowska-Wynimko J
Target Oncol; 2017 Apr; 12(2):179-200. PubMed ID: 28243959
[TBL] [Abstract][Full Text] [Related]
5. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
Guo JY; Hsu HS; Tyan SW; Li FY; Shew JY; Lee WH; Chen JY
Oncogene; 2017 Apr; 36(17):2457-2471. PubMed ID: 27819672
[TBL] [Abstract][Full Text] [Related]
6. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.
Flamini V; Jiang WG; Cui Y
Anticancer Res; 2017 Aug; 37(8):4319-4327. PubMed ID: 28739724
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment.
Yang N; Zhu S; Lv X; Qiao Y; Liu YJ; Chen J
Front Immunol; 2018; 9():2491. PubMed ID: 30443251
[TBL] [Abstract][Full Text] [Related]
9. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.
Frediani JN; Fabbri M
Mol Cancer; 2016 May; 15(1):42. PubMed ID: 27231010
[TBL] [Abstract][Full Text] [Related]
10. microRNAs and lung cancer: tumors and 22-mers.
Du L; Pertsemlidis A
Cancer Metastasis Rev; 2010 Mar; 29(1):109-22. PubMed ID: 20130964
[TBL] [Abstract][Full Text] [Related]
11. Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization.
Pirlog R; Cismaru A; Nutu A; Berindan-Neagoe I
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451052
[TBL] [Abstract][Full Text] [Related]
12. Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation.
Guo S; Deng CX
Int J Biol Sci; 2018; 14(14):2083-2093. PubMed ID: 30585271
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis.
Akshaya RL; Saranya I; Selvamurugan N
Breast Cancer; 2023 Nov; 30(6):910-925. PubMed ID: 37578597
[TBL] [Abstract][Full Text] [Related]
14. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression.
Zhang WC; Chin TM; Yang H; Nga ME; Lunny DP; Lim EK; Sun LL; Pang YH; Leow YN; Malusay SR; Lim PX; Lee JZ; Tan BJ; Shyh-Chang N; Lim EH; Lim WT; Tan DS; Tan EH; Tai BC; Soo RA; Tam WL; Lim B
Nat Commun; 2016 Jun; 7():11702. PubMed ID: 27325363
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
16. Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer.
Pirlog R; Chiroi P; Rusu I; Jurj AM; Budisan L; Pop-Bica C; Braicu C; Crisan D; Sabourin JC; Berindan-Neagoe I
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628157
[TBL] [Abstract][Full Text] [Related]
17. miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5.
Wang Y; Xu L; Jiang L
Biochem Biophys Res Commun; 2015 Mar; 458(3):714-719. PubMed ID: 25686496
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Li M; Zhang F; Su Y; Zhou J; Wang W
Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
[TBL] [Abstract][Full Text] [Related]
19. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
20. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
